# A Study of Zanubrutinib in Patients With ITP

> **NCT05279872** · PHASE2 · COMPLETED · sponsor: **Peking University People's Hospital** · enrollment: 20 (actual)

## Conditions studied

- Immune Thrombocytopenia
- Bruton Tyrosine Kinase

## Interventions

- **DRUG:** Zanubrutinib

## Key facts

- **NCT ID:** NCT05279872
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-01
- **Primary completion:** 2022-10-30
- **Final completion:** 2022-10-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05279872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05279872, "A Study of Zanubrutinib in Patients With ITP". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05279872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*